Corundum Neuroscience

A neuroscience-focused venture builder and fund advancing transformative neuroscience solutions from lab-to-life.

Venture Capital Active Herzliya, Israel Est. 2023
Visit website ↗ LinkedIn
Last updated 2026-07-20
Portfolio
2
in our dataset
Rounds participated
2
Rounds led
0
Rounds' value
$800K
total disclosed, rounds participated
Stages
B Round, Seed, F Round, G Round, D Round, A Round, C Round, E Round

About

Corundum Neuroscience, formerly Joy Ventures, is an Israeli venture builder and fund based in Herzliya, Israel. The firm focuses on advancing transformative neuroscience solutions from research to market. They support cutting-edge neuroscience research and build and fund ambitious companies developing innovative solutions for various health and disease areas, including anxiety, depression, PTSD, chronic pain, sleep, and neurodegenerative disorders. Corundum Neuroscience operates under its parent company, Corundum Innovation, and works to bridge the gap between early-stage research and market launch in the neuroscience technology domain.

Portfolio · 2

Sanga
Guided Meditation Platform
1 round Latest: 2018-07
Brain1
Brainwave Entrainment Device
1 round $800K committed Latest: 2018-01

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences10
Media & Entertainment Technologies1

Q&A

What is Corundum Neuroscience's primary investment focus?
Corundum Neuroscience focuses on advancing transformative neuroscience solutions, operating as a venture builder and fund.
Which investment stages does Corundum Neuroscience typically participate in?
Corundum Neuroscience participates in a wide range of investment stages, including Seed, A Round, B Round, C Round, D Round, E Round, F Round, and G Round.
Can you name some of Corundum Neuroscience's notable portfolio companies?
Corundum Neuroscience's portfolio includes companies such as GrayMatters Health, which develops digital therapy for mental health, and Lumen, a virtual nutritionist and metabolism measurement device.
What is Corundum Neuroscience's geographic focus for investments?
Corundum Neuroscience is based in Herzliya, Israel, and its parent company, Corundum Innovation, is a Japanese-based investment firm. The data does not specify preferred geographies beyond this.
What is the typical investment range for Corundum Neuroscience?
Corundum Neuroscience's investment range is between $720K and $20M.
Has Corundum Neuroscience had any notable exits?
Yes, WISDO HEALTH, a social health platform, was acquired by Talkspace in October 2025.
What is the sector concentration of Corundum Neuroscience's portfolio?
The majority of Corundum Neuroscience's portfolio companies, 10 out of 11, are in the Health Tech & Life Sciences sector. One company is in Media & Entertainment Technologies.
When was Corundum Neuroscience founded?
Corundum Neuroscience was founded in 2016.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)